key: cord-0711122-tkus4ijg
authors: Hopkins, Claire; Lechien, Jerome R.; Saussez, Sven
title: More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival
date: 2020-11-20
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.110406
sha: feb2e656bc99b3b7dacdb3b3622633df9b8f3605
doc_id: 711122
cord_uid: tkus4ijg

Three mechanisms have been proposed to account for COVID-19 associated olfactory dysfunction; obstruction of the olfactory cleft; epithelial injury and infection of the sustentacular supporting cells, which are known to express ACE2, or injury to the olfactory bulb due to axonal transport through olfactory sensory neurones. The absence of ACE2 expression by olfactory sensory neurones has led to the neurotropic potential of COVID-19 to be discounted. While an accumulating body of evidence supports olfactory epithelial injury as an important mechanism, this does not account for all the features of olfactory dysfunction seen in COVID-19; for example the duration of loss in some patients, evidence of changes within the olfactory bulb on MRI imaging, identification of viral particles within the olfactory bulb in post-mortem specimens and the inverse association between severity of COVID-19 and the prevalence of olfactory loss. The recent identification of a second route of viral entry mediated by NRP1 addresses many of these inconsistencies. Expression by the olfactory sensory neurones and their progenitor cells may facilitate direct injury and axonal transport to the olfactory bulb as well as a mechanism for delayed or absent recovery. Expression by regulatory T cells may play a central role in the cytokine storm. Variability in expression by age, race or gender may explain differing morbidity of infection and inverse association between anosmia and severity; in the case of higher expression there may be a higher risk of olfactory function but greater activation of regulatory T cells that may suppress the cytokine storm.

Three mechanisms have been proposed to account for COVID-19 associated olfactory dysfunction; obstruction of the olfactory cleft; epithelial injury and infection of the sustentacular supporting cells, which are known to express ACE2, or injury to the olfactory bulb due to axonal transport through olfactory sensory neurones. The absence of ACE2 expression by olfactory sensory neurones has led to the neurotropic potential of COVID-19 to be discounted.

While an accumulating body of evidence supports olfactory epithelial injury as an important mechanism, this does not account for all the features of olfactory dysfunction seen in COVID-19; for example the duration of loss in some patients, evidence of changes within the olfactory bulb on MRI imaging, identification of viral particles within the olfactory bulb in post-mortem specimens and the inverse association between severity of COVID-19 and the prevalence of olfactory loss.

The recent identification of a second route of viral entry mediated by NRP1 addresses many of these inconsistencies. Expression by the olfactory sensory neurones and their progenitor cells may facilitate direct injury and axonal transport to the olfactory bulb as well as a mechanism for delayed or absent recovery. Expression by regulatory T cells may play a central role in the cytokine storm. Variability in expression by age, race or gender may explain differing morbidity of infection and inverse association between anosmia and severity; in the case of higher expression there may be a higher risk of olfactory function but greater activation of regulatory T cells that may suppress the cytokine storm.

Keywords COVID, olfactory loss, disease severity, neurotropism, neuropilin Introduction Olfactory dysfunction (OD) has now been shown to be one of the most prevalent symptoms of COVID-19 (1) , and the best predictor of COVID-19 status of all the associated symptoms (2) . However the underlying mechanism has yet to be fully elucidated.

In terms of the underlying pathophysiology, several hypotheses were proposed at the outset of the pandemic; that viral induced injury to the olfactory epithelium leads to olfactory cleft inflammation and obstruction causing a localized conductive loss, that injury to the olfactory epithelium caused a sensorineural deficit directly or, given the known neurotropic potential of coronavirus, that the virus could invade and damage the olfactory bulb(3).

Current thinking is that olfactory epithelial injury is the predominant underlying mechanism, mediated by infection of the sustentacular cells which express ACE2.

Our hypothesis is that all three mechanisms likely play a part; early olfactory cleft obstruction occurs secondarily to olfactory epithelial injury mediated by ACE2 related cell infection. However, in those patents with more persistent olfactory deficits, there is direct injury to olfactory sensory neurones and consequently the olfactory bulb, facilitated by NRP1 mediated cell entry and infection. Loss of the progenitor cells may lead to permanent loss in some patients Is olfactory dysfunction due to obstruction of the nasal cavity and olfactory cleft?

We performed sinus computed tomography in patients with persistent anosmia on psychophysical olfactory evaluation but found that few had complete bilateral obstruction of the olfactory cleft(4), suggesting that while olfactory cleft obstruction may contribute to the olfactory dysfunction in some patients, perhaps most likely in those that show very early resolution, it cannot account for the loss in all patients.

CoV-2, like SARS-CoV, has been shown to infect cells through binding of its spike protein to ACE2 proteins on target cells (5) . Chen The current proposed model of epithelial injury secondary to ACE2 mediated entry also does not fully explain the apparent inverse association between OD and severity of disease. Yan et al. a found that self-reported olfactory loss associates with milder forms of disease in patients who did not require hospitalization (16) . There is a risk that this represents recall bias due to the over-riding severity of respiratory symptoms and delays in olfactory testing of such patients compared to those with mild disease. Older patients are at higher risk of more severe disease; of course olfactory function diminishes with increasing age (17) and, therefore, hospitalized patients may simply have higher rates of pre-existing loss and may be less able to detect further decline.

However, if it is indeed true that OD is less prevalent in more severe forms, what mechanism may account for this? Nasal gene expression of ACE2 was studied on biobank samples taken from individuals aged between 4 and 60 years old, and was found to increase with age; unfortunately, samples from older patients were not available for comparison (18) . As COVID related anosmia appears rare in childhood, and most prevalent in the 40-50 year old age group, perhaps this is related to peak expression in ACE2?

Ablation of the olfactory bulb may prevent anterograde propagation of the virus to the olfactory bulb in murine models of viral infection (19, 20) . Thus, given the capacity to of the olfactory neurones to regenerate, it has been proposed that apoptosis of infected olfactory receptor neurons may be a programmed protective response to neurotropic viruses that lessens the severity of infection (21) . The lower prevalence of anosmia in more severe disease may reflect a failure of this line of defence -but this again does not sit well with a ACE2 mediated route of entry. Furthermore, COVID-19 mortality seems to relate more to the associated cytokine storm rather than central nervous system complications (22) .

Perhaps the missing piece of the jigsaw has been discovered. Two teams have independently discovered an alternative pathway of SARS-CoV-2 entry mediated by the neuropilin-1 receptor (NRP1), which can also bind with the Spike protein (23, 24) . Cantuti-Castelvetri and colleagues also demonstrated abundant expression of NRP1 in almost all olfactory cells, including neuronal progenitor cells and OSNs in post-mortem olfactory epithelial specimens (23) .

Binding to NRP1 could facilitate direct entry and damage to OSNs causing loss of smell, loss of the progenitor cells leading to delayed recovery, and permit axonal transport to the olfactory bulb; this NRP1 mediated mechanism may be responsible for the more persistent olfactory dysfunction seen in some COVID-19 patients.

Could this also explain the inverse relationship between olfactory dysfunction and disease severity? Neuropilins are involved in many physiological processes, including neuronal development, angiogenesis but also immune regulation.

Amongst other immune cells, NRP1 is expressed by regulatory T cells and appears to exert an immunosuppressive effect -perhaps those most susceptible to NRP1 mediated olfactory loss due to higher expression are at the same time better equipped to suppress the cytotoxic storm that is seen in COVID-19, through activation of regulatory T cells? Production of regulatory T cells declines with age (25) , and are down-regulated in obesity (26) . Racial variation in T-cell function has also been described; while higher rates of malignancy described in African-Americans is multifactorial (27) , they have been shown to have higher levels of T helpers cells and lower levels of regulatory T cells -the same variation could contribute to higher mortality from a cytokine storm in COVID-19 .

Finally, regulatory T cells are often associated with chronic viral infection, while some acute forms are characterised by hyper-inflammation but viral clearance -perhaps this is why many patients with olfactory disturbance and a relatively mild initial course report long-lasting fluctuation symptoms associated with Long-COVID.

If NRP1 is the link between olfactory loss and enhanced survival, and given that the majority of patients recover from their olfactory dysfunction, perhaps this is a reasonable price to pay. However, better understanding of the pathophysiology may allow uncoupling of olfactory loss and severity of disease so that better outcomes with regards to both short and long term olfactory dysfunction can be achieved while reducing the risk of mortality. Further study into variation in the expression on NRP1 is clearly required, along with enhanced understanding of the role in both olfactory dysfunction and disease severity. However, this finding highlights the importance of remaining openminded to the possibility of alternative mechanisms to those that emerged as early front-runners. Perhaps we have become too blinkered by the allure of ACE2 and this has been detrimental to progress.

Clinical and epidemiological characteristics of 1420 European patients with mild-tomoderate coronavirus disease 2019

Real-time tracking of self-reported symptoms to predict potential COVID-19

Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered

Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication

Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

Inflammatory olfactory neuropathy in two patients with COVID-19

Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters

Olfactory epithelium histopathological findings in longterm COVID-19 related anosmia. Accepted for publication on

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem

Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia

Bilateral transient olfactory bulb edema during COVID-19-related anosmia

Self-reported olfactory loss associates with outpatient clinical course in COVID-19

Longitudinal changes in smell identification. The journals of gerontology Series A, Biological sciences and medical sciences

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults

Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves

Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain

Is anosmia the price to pay in an immune-induced scorchedearth policy against COVID-19? Medical hypotheses

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Age-Dependent Changes in Regulatory T Lymphocyte Development and Function: A Mini-Review

A Unique Population: Adipose-Resident Regulatory T Cells

Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer

Acknowledgements -We have not received any funding to support this work Ethical approval was not required for this manuscript